Latest Period
Q1 2026
Security Snapshot
Satellos Bioscience Inc. - Common Shares (MSLE) Institutional Ownership
CUSIP: 80401L803
13F Institutional Holders and Ownership History for Q1 2026
Institutions Reporting
31
Shares (Excl. Options)
7,597,066
Price
$5.63
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- MSLE on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 7,597,066
- Total 13F value
- $42,791,195
- Portfolio coverage rank
- 0%
- Share change
- +7,597,066
- Value change
- +$42,791,195
- Number of holders
- 31
- Shares outstanding
- 15,420,422
- SEC-reported price per share
- $6.98
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MSLE - Satellos Bioscience Inc. - Common Shares is tracked under CUSIP 80401L803.
- 31 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Latest quarter on this page is Q1 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 31 institutions filings for Q1 2026.
Security key
80401L803
Latest holder period
Q1 2026
13F holders
31
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
MSLE full holder history
Satellos Bioscience Inc. SEC filings
Satellos Bioscience Inc. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 80401L803:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
MSLE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. | 8.3% | $9,713,658 | 1,725,247 | Qiming U.S. Healthcare Fund III, L.P. | 31 Mar 2026 | |||
| Bloom Brian Matthew | 7.4% | $6,381,048 | 1,133,401 | Brian Matthew Bloom | 06 Feb 2026 |
As of 31 Mar 2026, 31 institutional investors reported holding 7,597,066 shares of Satellos Bioscience Inc. - Common Shares (MSLE). This represents 49% of the company’s total 15,420,422 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
49%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 6.1% | 938,666 | 0% | $5,305,467 | |
| Siren, L.L.C. | 5.8% | 892,074 | 0.14% | $5,022,377 | |
| Vivo Capital, LLC | 5.3% | 813,666 | 0.38% | $4,580,940 | |
| Point72 Asset Management, L.P. | 4.5% | 690,778 | 0.01% | $3,889,080 | |
| Woodline Partners LP | 3.2% | 500,432 | 0.01% | $2,817,432 | |
| SPHERA FUNDS MANAGEMENT LTD. | 3.2% | 489,207 | 0.47% | $2,754,235 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3.1% | 475,000 | 0.07% | $2,674,250 | |
| Soleus Capital Management, L.P. | 2.7% | 414,359 | 0.09% | $2,332,841 | |
| Avidity Partners Management LP | 2.5% | 387,769 | 0.43% | $2,183,139 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.5% | 380,354 | 0% | $2,141,393 | |
| Saturn V Capital Management LP | 2.3% | 350,000 | 0.36% | $1,970,500 | |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 298,433 | 0% | $1,680,178 | |
| 683 Capital Management, LLC | 1.5% | 230,833 | 0.12% | $1,299,590 | |
| Empery Asset Management, LP | 1.5% | 230,100 | 1.6% | $1,295,463 | |
| ADAR1 Capital Management, LLC | 1.4% | 222,555 | 0.08% | $1,253,000 | |
| Stonepine Capital Management, LLC | 0.65% | 100,000 | 0.5% | $563,000 | |
| CITADEL ADVISORS LLC | 0.28% | 42,492 | 0% | $239,230 | |
| HRT FINANCIAL LP | 0.2% | 30,461 | 0% | $171,000 | |
| MORGAN STANLEY | 0.14% | 21,183 | 0% | $119,260 | |
| JANE STREET GROUP, LLC | 0.13% | 19,608 | 0% | $110,399 | |
| ROYAL BANK OF CANADA | 0.11% | 16,245 | 0% | $91,000 | |
| Monashee Investment Management LLC | 0.08% | 12,000 | 0.04% | $67,560 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.08% | 11,907 | 0% | $67,036 | |
| Propel Bio Management, LLC | 0.07% | 10,145 | 0.04% | $57,116 | |
| AXQ CAPITAL, LP | 0.07% | 10,096 | 0.01% | $56,840 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Latest
Q1 2026
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 7,597,066 | $42,791,195 | +$42,791,195 | $5.63 | 31 |